Clinical trials in dry eye in surgery for dry eye?

Developments in Ophthalmology

Volumn 41, Issue , 2008, Pages 283-297

  Lemp, M ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DRY EYE; EYE SURGERY; HUMAN; METHODOLOGY; REVIEW; STANDARD; VISUAL SYSTEM EXAMINATION;

CLINICAL TRIALS AS TOPIC; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; RESEARCH DESIGN;

EID: 47949096800     PISSN: 02503751     EISSN: 16622790     Source Type: Book Series    
DOI: 10.1159/000131096     Document Type: Review

References (32)

1. Atkins H: Conduct of a clinical trial. Br J Ophthalmol 1966;2:377.
2. Ederer F: The randomized clinical trial; in Philips CJ, Wolfe JN (eds): Clinical Practice and Economics. Bath, Pitman Press, 1977.
3. Maitland D: Clinical trials and health care administrators (1969): Note 42. Notes on Biometry in Medical Research. Washington, Va Monogr 10-1 (Suppl U).
4. Lewis TR: Research in medicine: its position and needs. 3/15/30 Br Med J 479.
5. Kupfer C: Evaluating new approaches to the treatment of eye and vision disorders. NIH Publ No 90-2910 (1990).
6. Hrobjartsson A, Gotzsche PC: Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-1602.
7. Weihrauch TR, Gauler TC: Placebo efficacy and adverse effects in clinical trials. Arzneimittelforschung 1999;49:385-393.
8. Kienle GS, Kiene H: The powerful placebo effect: fact or fiction? J Clin Epidemiol 1997;50:1311-1318.
9. Nelson JD (pers commun) cited in Foulks GN: Challenges and pitfalls in clinical trials of treatments for dry eye. Ocul Surf 2003;1:20-30.
10. Sall K, Stevenson OD, Mundorf TK, et al: Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye. CsA Phase 3 Study Group. Ophthalmology 2000;107:631-619.
11. Lemp MA: Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eye. CLAO J 1995;21:221-232.
12. Shimazaki J, Goto M, et al: Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology 1998;105:1485-1488.
13. Tauber J, Davitt WF, Bokosky JE et al: Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS 365) ophthalmic solution for the treatment of dry eye. Cornea 2004;23:784-792.
14. Foulks GN: Challenges and pitfalls in clinical trials of treatments for dry eye. Ocul Surf 2003;1: 20-30.
15. Schaumberg DA, Sullivan DA, Buring JE, Dana MR: Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003;36:318-326.
16. Nichols KK, Nichols JJ, Mitchell GL: The reliability and validity of McMonnies' dry eye index. Cornea 2004;23:365-371.
17. Begley CG, Chalmers RL, Abetz L, Venkataraman K, et al: The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthal Vis Sci 2003;44:4753-4761.
18. Korb DR, Korb JM: Corneal staining prior to contact lens wearing. J Am Optom Assoc 1970;41: 228-232.
19. Tseng S: Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985;92:729-733.
20. Nelson JD, Harverner V, Cameron J: Cellulose acetate impressions of the ocular surface in dry eye states. Arch Ophthalmol 1983;101:1869-1883.
21. Abelson MB, Ousler GW, Nally LA, Krenzer K: Alternative reference values for tear film break-up time in normal and dry eye populations. Cornea 2000;19:S72.
22. Kojima T, Ishida R, Dogru M, et al: A new noninvasive tear stability analysis system for the assessment of dry eyes. Invest Ophthalmol Vis Sci 2004;45:1369-1374.
23. Sullivan B, Angeles R, Schanzlin D, et al: A new nanoliter tear osmometer for the diagnosis of dry eye. 4th International Tear Film, Ocular Surface Disease and Dry Eye Symposium, Puerto Rico 2004.
24. Rolando M, Barabino S, Mingari C, Moretti S, et al: Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea 2005;24:951-954.
25. Goto E, Yagi Y, Matsumoto Y, Tsubota K: Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002;133:181-186.
26. Ishida R, Kojima T, Dogru M, Kaido M, et al: The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol 2005;139:253-258.
27. Montes-Mico R, Alio JL, Charman WN: Dynamic changes in the tear film in dry eyes. Invest Ophthalmol Vis Sci 2005;46:1615-1619.
28. Ousler GW, Gomes PJ, Welch D, Abelson MB: Methodologies for the study of ocular surface disease. Ocul Surf 2005;3:143-154.
29. ARVO statement on registering clinical trials. Invest Ophthalmol Vis Sci 2006;47:1-2.
30. DeAngelis CD, Drazen JM, Frizelle FA, et al: Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 2005;293: 2927-2929.
31. Levin LA, Gottlieb JL, Beck RW, et al: Registration of clinical trials. Arch Ophthalmol 2005;123: 1263-1264.
32. Fredrickson DS: The field trial: some thoughts on the indispensable ordeal. Bull NY Acad Med 1968;44:985.